Boston Scientific Q3 Beats Expectations, Emerging Markets Boost Biz

25 Oct 2019

• By Catherine Longworth

Boston Scientific reported higher than expected Q3 results, with growth across emerging markets boosting company revenue. A number of product launches across the business also helped to drive growth.

Quarterly resluts on typewriter close up

Boston Scientific Corp. reported sales of $2.7bn during Q3 2019, a year-on-year increase of 13.1%, exceeding analyst expectations.

Growth was driven by strength across geographic and business divisions, including Interventional cardiology (14.6%), endoscopy (10.4%), urology and pelvic health...